Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.
- DOI
- 10.1002/mco2.70854
- Published
- 2026 Jul
- Container
- MedComm
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/mco2.70854,
title = {Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.},
author = {Zou Z and Zheng X and Tian P and Liu Z and Hu J and Fang Y and Xia Y and Ye F and Lv T and Li L and Zhong D and Zhou J and Chu Q and Shi M and Han C and Cao B and Huang D and Guo H and Lin G},
year = {2026},
journal = {MedComm},
doi = {10.1002/mco2.70854},
url = {https://doi.org/10.1002/mco2.70854}
}RIS
TY - JOUR TI - Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study. AU - Zou Z AU - Zheng X AU - Tian P AU - Liu Z AU - Hu J AU - Fang Y AU - Xia Y AU - Ye F AU - Lv T AU - Li L AU - Zhong D AU - Zhou J AU - Chu Q AU - Shi M AU - Han C AU - Cao B AU - Huang D AU - Guo H AU - Lin G PY - 2026 JO - MedComm DO - 10.1002/mco2.70854 UR - https://doi.org/10.1002/mco2.70854 ER -
APA
Z, Z., X, Z., P, T., Z, L., J, H., Y, F., Y, X., F, Y., T, L., L, L., D, Z., J, Z., Q, C., M, S., C, H., B, C., D, H., H, G., & G, L. (2026). Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.. MedComm. https://doi.org/10.1002/mco2.70854
Source records
- pubmed · retrieved 2026-09-26T03:14:26.057Z